Engaging patients for drug repurposing: mapping the patient engagement continuum The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing. Read More... Exploring open innovation with a patient focus in drug discovery: an evolving paradigm of patient engagement It is suggested in this article that patient engagement should occur further upstream during the drug discovery stage. ‘Lead patients’, namely those patients who are proactive with respect to their health, possess knowledge of their disease and resulting symptoms. They are also well informed about the conventional as well as non-conventional treatments for disease management; and so can provide a nuanced perspective to drug design. Read More...
Learning from the Tres Cantos and AMANET Models of Collaboration
Open-source approaches for the repurposing of existing or failed candidate drugs
Open Innovation Case Study: Novartis Institutes for Biomedical Research
Open Innovation Case Study: Pfizer's Centers for Therapeutic Innovation
Open Innovation Case Study: GSK's Centres for External Drug Discovery